GlassScriptPhysician profile
Jeff D Chancellor
NPI 1104886126
$9,724.78
in general payments reported to CMS, 2019-2025
22 companies · $430 in 2025
The $430 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $281 · 2020: $4,150 · 2021: $4,150 · 2022: $94.03 · 2023: $316 · 2024: $303 · 2025: $430.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,050.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,316.00 | 2020-2022 | |
| Abbvie INC. | $348.99 | 2019-2025 | Lo Loestrin Fe, Orilissa |
| Sumitomo Pharma America, INC. | $184.46 | 2023-2025 | Myfembree, Gemtesa |
| Amag Pharmaceuticals, INC. | $88.30 | 2019 | |
| Astellas Pharma US INC | $87.62 | 2023-2025 | Veozah |
| Pfizer INC. | $83.61 | 2019-2024 | |
| Organon LLC | $74.90 | 2023-2025 | Nexplanon, Nuvaring |
| Boston Scientific Corporation | $74.76 | 2022-2024 | |
| Mayne Pharma Commercial LLC | $70.55 | 2023-2025 | |
| Duchesnay USA Incorporated | $62.45 | 2019 | |
| Hologic Sales and Service, LLC | $59.05 | 2024-2025 | Aptima, Novasure |
| Biogen, INC. | $54.30 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $45.51 | 2023-2024 | Slynd |
| Merck Sharp & Dohme LLC | $36.97 | 2019 | |
| Exact Sciences Corporation | $22.73 | 2025 | The Cologuard Plus Collection Kit |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $19.71 | 2024 | |
| Evofem Biosciences, INC. | $19.45 | 2024 | |
| Bard Access Systems, INC. | $17.65 | 2019 | |
| Minerva Surgical, INC | $16.43 | 2023 | |
| Therapeuticsmd, INC. | $16.38 | 2019 | |
| Dexcom, INC. | $13.76 | 2023 | Dexcom G6 Transmitter |
| Mission Pharmacal Company | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeff Chancellor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.